We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
+11.36%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
–
AUM
$879M
AUM Growth
+$173M
Cap. Flow
+$173M
Cap. Flow %
19.73%
Top 10 Hldgs %
100%
Holding
8
New
3
Increased
–
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
TNYA icon
Tenaya Therapeutics
TNYA
+$202M
2
SRZN icon
Surrozen
SRZN
+$86.8M
3
EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
+$55.6M

Top Sells

Rank Stock Value
1
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$88.8M
2
RAPT
RAPT Therapeutics
RAPT
+$82.1M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$324M 36.81%
15,396,116
– –
TNYA icon
2
Tenaya Therapeutics
TNYA
$163M
$194M 22.08%
+9,400,290
New +$202M
ORIC icon
3
Oric Pharmaceuticals
ORIC
$1.44B
$99.7M 11.34%
4,768,181
– –
RVMD icon
4
Revolution Medicines
RVMD
$43.7B
$92.1M 10.47%
3,347,245
– –
SRZN icon
5
Surrozen
SRZN
$282M
$65.5M 7.45%
+616,542
New +$86.8M
EFTR
6
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$60.5M 6.89%
+172,373
New +$55.6M
RAPT
7
DELISTED
RAPT Therapeutics
RAPT
$43.5M 4.95%
175,251
-310,459
-64% -$82.1M
CNST
8
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
– –
-2,626,631
Closed -$88.8M

Similar funds

PIS
POM Investment Strategies Raleigh, North Carolina $88.3M AUM 15.23% 1-Year Est. Return
FWM
FSR Wealth Management Elmhurst, Illinois $87.8M AUM 10.63% 1-Year Est. Return
WP
Walleye Partners Madison, Wisconsin $87.7M AUM
SHCM
Stone House Capital Management Bay Harbor Islands, Florida $88.5M AUM 149.16% 1-Year Est. Return
YIM
Yoffe Investment Management Lemoyne, Pennsylvania $87.4M AUM 30.8% 1-Year Est. Return
VPW
Variant Private Wealth Tysons, Virginia $88.9M AUM 25.07% 1-Year Est. Return
LC
Luminist Capital Grand Rapids, Michigan $89M AUM 17.66% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Column Group's Q3 2021 Portfolio in Review

As of Q3 2021, Column Group held 8 positions worth $879M, up 24% from $707M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Column Group deployed $173M of net new capital in Q3 2021, opening 3 new positions. Its largest new stake was Tenaya Therapeutics: 9,400,290 shares worth $194M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was RAPT Therapeutics, an estimated $82.1M trimmed.

  • Column Group's largest Q3 2021 buy was Tenaya Therapeutics: 9,400,290 shares worth $194M.
  • Column Group's biggest Q3 2021 reduction was RAPT Therapeutics, cutting an estimated $82.1M.
  • Column Group fully exited Constellation Pharmaceuticals, Inc. in Q3 2021, selling an estimated $88.8M.
  • Column Group's ten largest holdings make up 100% of its $879M portfolio in Q3 2021.
  • Column Group opened 3 new positions and closed 1 in Q3 2021.
  • Column Group's portfolio value rose 24% quarter-over-quarter to $879M.

Based on Column Group's 13F filing for Q3 2021, filed 12 Nov 2021.